2007 Jan Feb March April May June July August Sep Oct Nov Dec |
December
|
December 22/29
|
Raynaud’s phenomenon
In our continuing professional development article on Raynaud’s
phenomenon (PJ, 8 December 2007) the dose (unlicensed) for
iloprost intravenous infusion (p650) should have read 2ng/kg/min and
not 2ng/kg.
Schering
Health advises that the dose is adjusted according to individual tolerability
within the range of 0.5 to 2.0ng/kg/min over six hours daily.
Treatment
periods of three to five days are often sufficient in Raynaud’s
phenomenon to achieve improvement over several weeks. |
December 8
|
ESCP report
Dosing information about
5-fluorouracil was incorrect in
The Journal’s report of Julie Fisher’s presentation
at the European Society of Clinical Pharmacy conference (PJ,
24 November, p597).
5-fluorouracil is administered to patients over
seven days, not five days as stated (ibid,
p598). |
November
|
November 17
|
CLARIFICATION:
Clarke Inquiry panel
Information provided by the Clarke Inquiry about panel member Peter Owen
was incorrect. Mr Owen ceased to be secretary general of the Institute
of Chartered Accountants in 2003 (PJ, 3
November 2007, p493).
CLARIFICATION: Digital CD log
Nader Siabi has now said that the Royal Pharmaceutical Society has
not approved his software for keeping Controlled Drug records (PJ,
3 November
2007, p490). |
November 10
|
CLARIFICATION: Eprex
Eprex (epoetin alfa; Janssen-Cilag) solution for injection 40,000 units continues
to be available in prefilled syringes; only the vials have been discontinued
(PJ, 3 November, p495).
|
November 3
|
Nomad MDS
Nomad monitored dosage system was developed by Surgichem not Protomed as suggested
in last week’s issue (p463).
|
October
|
October 6
|
Atriance
The price of Atriance (PJ,
15 September, p286) should have read “6 x 250mg/50ml
vials, £1,332”, and not as stated.
The Journal was supplied with
incorrect information.
Heather Simmonds
In the letter we published from Heather
Simmonds on 22 September (p325),
we wrongly attributed the designation “MRPharmS”. Mrs Simmonds
is not a member of the Royal Pharmaceutical Society. |
September
|
September 29
|
Servier awards
The winners of this year’s Servier
awards were presented with grants and
cheques by Alasdair MacCulloch of Servier Laboratories Ltd and not as stated
in a British Pharmaceutical Conference report (PJ, 15 September, p298).
|
September 15
|
CLARIFICATION: Gerald Wilkinson tribute
The tribute to the late Gerald
Louis Wilkinson, which appeared last week (p276),
was written by John L. Woodward, MRPharmS.
CORRECTION: Aliskiren
The second paragraph within the Panel “How
Aliskiren works” in
last week’s News section (PJ,
8 September, p251) should have read: “Aliskiren directly inhibits renin, which converts angiotensinogen to angiotensin-I. Angiotensin-I is then converted to angiotensin-II (ACE inhibitors block this step), triggering vasoconstriction (ARBs stop angiotensin-II receptor binding).”
Information
pharmacists
The period on Thursdays when Royal Pharmaceutical Society information
pharmacists can be contacted was incorrectly given last week (p271).
The correct period is 10am to 5pm, and not 9am to 5.45pm as stated. |
August
|
August 18
|
Registration examination
There was an error in the list supplied to The Journal of successul candidates
in the Royal Pharmaceutical Society’s registration examination published
on 28 July (p111). The name
Sajeel Abid is incorrect.
The correct name is Sajeel Abrar. |
August 11
|
Premises fees
The proposed fees for premises registration, retention and restoration given
last week in the Table on p129 were incorrect.
The correct proposed
fees are announced this week (p162).
|
July
|
July 28
|
Correction: Industry code breaches
A news report last week (p65) should have said that Bayer, GlaxoSmithKline and
Roche were publicly reprimanded in our 7 July issue (inside front cover) and
not as reported.
CLARIFICATION: Code of Ethics
The Code of Ethics for Pharmacists and Pharmacy Technicians distributed with
last week’s issue is the actual code that comes into effect on 1 August,
and not a preview as was suggested
(PJ, 21 July,
p83).
Registrants are asked to retain it.
|
July 21
|
BPC organiser
Unfortunately, we were supplied with the wrong contact information for Angela
Lyons of Health Links, the organiser of the 2007 British Pharmaceutical Conference
(PJ, 7 July,
p29). Her telephone number is 0121 248 3399, and her e-mail
address
is alyons@health-links.co.uk
The Journal
The issue number on the cover of last week’s Journal should have
been 7460. |
June
|
June 23
|
CLARIFICATION Journal packaging
In the editor’s response to David
Knott’s letter (PJ, 19 May, p586)
we gave misleading information provided by the supplier about the cost of distributing
The Journal in biodegradable polywrap. We have investigated the options further
and it is cost effective to switch to biodegradable polywrap, which will take
place from this issue.
CORRECTION Brian Curwain’s letter
Brian Curwain (PJ, 16 June, p704) was described as “chief pharmacist” at
Hampshire PCT. This was an editorial error; he does not hold this post and wishes
to make this clear in fairness to his colleagues.
|
June 9
|
Counterfeit lot number
One of the lot numbers of counterfeit
Zyprexa was listed incorrectly as A21645
in last week’s product recall (PJ, 2 June, p641). The number should have
read: A216454.
|
May
|
May 19
|
NAWP president
Hazel Baker, MRPharmS, has been appointed president of the National Association
of Women Pharmacists, not Veronica Pearson as reported (PJ, 5 May, p519). The
Journal was supplied with erroneous information.
|
May 12
|
CLARIFICATION: NPA board
Further to last week’s correction (PJ, 5 May, p519) to the inaccurate list
of National Pharmacy Association board members provided by the NPA, the NPA board
member for North West London is Hiten Patel.
Carole Brown’s letter
The second sentence of the third paragraph of Carole
Brown’s letter (PJ,
5 May, p524) should have read: “On returning to the surgery, pharmacists
discussed the reviews with the GP and suggestions were actioned.”
|
May 5
|
NPA board members
The list of National Pharmacy Association management
board members (as supplied by the NPA) printed last
week was incorrect (PJ, 28 April, p476). As stated, Dilip Joshi is chairman
of
the board for 2007–08. However, the other members of the board are: Raj
Aggarwal, Gerald Alexander, Ian Cubbin, John Currie, Wally Dove, Ian Facer, Bob
Gould, Michael Guerin, Tricia Kennerley, Coll Michaels, Andy Murdock, Rakesh
Panesar, Bharat Patel, Rajesh Patel, Umesh Patel, Ashok Soni and Sean Woodward
CPD
In the Continuing professional development article
on potassium last
week (PJ, 28 April) the second bullet point in Panel 1 (p497) should
have read “alkalosis” rather than “acidosis”.
|
April
|
April 28
|
CLARIFICATION: Queen’s Awards
The Queens Awards for Enterprise reported
in the news pages of last week’s
Journal (PJ, 21 April, p448) are separate awards. The University of Nottingham
School of Pharmacy received an award for “Pharmaceutical applications of
nanotechnology” and Molecular Profiles Ltd, for “Contract analysis
and research services to pharmaceutical and biomedical companies”.
|
April 14
|
Erasure from Register
The names of 34 persons who had indicated their wish to retire voluntarily
from the Register of Pharmaceutical Chemists were included erroneously
in the Royal
Pharmaceutical Society’s official notice listing pharmacists
erased from the Register for
non-payment of the retention fee for 2007 (PJ, 7 April, p409).
The
Society apologises for the error and for any embarrassment caused.
The
34 are as
follows (registration numbers in parentheses):
T. Alvarez Esteban (1076935)
J. M. Barr (54604)
M. Barral Juez (1074473)
I. D. Blackburn (61962)
M. L. Chan (90064)
L. M. Cramer (R6384)
D. L. Crooks (1078590)
T. C. Draysey (1082050)
R. M. Fenwick (1071705)
A. E. Forrest (R5105)
L. R. Graham (61070)
A. E.
Haynes (39239)
J. A. Host (1081124)
L.M. Houlihan (1074877)
M. L.
Ko (71419)
L. I. McDermid (73096)
A. D. Martin (83097)
I. A. Nazroo
(44996)
A. J. Parton (54236)
M. M. Patel (61315)
D. Satikidou (1085488)
L. P. Shah (89914)
E. M. Shanahan (1080360)
M. C. Sharpe (64786)
N. M. Sharpe (66897)
R. G. Stephenson (50633)
A. C.
Taylor (55451)
K. D. Teague (1072310)
A. K. Tiwana (87681)
S. P.
Uren (93224)
M. Walker (62538)
K. A. J. Williams (41315)
F. M. Wood
(41179)
D. M. Wood (41239) |
March
|
March 10
|
IPG Committee election
An Official Notice inviting nominations for election to the Industrial
Pharmacists Group Committee, published in each issue of The Journal in
February, wrongly stated that each nomination had to be signed by at least
five group members. In fact, no more than one nominator is required. A
corrected
notice appears on p293.
McKesson Corporation
It is the US McKesson Corporation that provides services to community
pharmacy businesses and not as stated last week (p235).
|
March 3
|
Society’s assets
The Society’s assets were valued at £5.246m in its 2005 accounts,
not £5,246m, as stated in a news item last week (PJ, 24 February,
p207).
|
February
|
February 17
|
IPG committee
Due to an administrative error a Notice-board item “IPG committee” listed
current members of the Industrial Pharmacists Group committee, not newly
elected members (PJ,
10 February, p161 PDF 60K);
nominations for the IPG committee election are still open.
See Society p203 |
January
|
January 13
|
UKPPG
At the UK Psychiatric Pharmacy Group meeting (PJ, 11 November, p587), Mark
Harnden was glad the professionals with whom he came into contact had persevered
with him, rather than he was grateful that he had persevered with the professionals,
as stated.
|
Acrobat
Reader